Sulfuric Acid

Sulfuric Acid

SCHEMBL1697122

CCCCCCCC[N+](CCCCCCCC)(CCCCCCCC)CCCCCCCC.O=S(=O)([O-])[O-].[H+]

nearest known ligand 0.65

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
SLC22A1 O15245 3/20 0.65
ALDH1A1 P00352 1/20 0.62
TP53 P04637 1/20 0.62
CYP3A4 P08684 1/20 0.62
ALOX15 P16050 1/20 0.62
TSHR P16473 1/20 0.62
ALOX12 P18054 1/20 0.62
SMN1; SMN2 Q16637 1/20 0.62
HIF1A Q16665 1/20 0.62
HSD17B10 Q99714 1/20 0.62
SLC22A2 O15244 1/20 0.60
DNM1 Q05193 6/20 0.56
LSS P48449 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sulfuric Acid SCHEMBL4372098 1.00 SLC22A1 (0.65) SLC22A1ALDH1A1TP53CYP3A4ALOX15
Tetrahexylammonium SCHEMBL444046 1.00 SLC22A1 (0.65) SLC22A1ALDH1A1TP53CYP3A4ALOX15
Tetrahexylammonium SCHEMBL3641187 0.98 SLC22A1 (0.62) SLC22A1ALDH1A1TP53CYP3A4ALOX15
Sulfuric Acid SCHEMBL9792101 0.98 SLC22A1 (0.62) SLC22A1ALDH1A1TP53CYP3A4ALOX15
Sulfuric Acid SCHEMBL11344200 0.97 SLC22A1 (0.68) SLC22A1ALDH1A1TP53CYP3A4ALOX15
Tetrahexylammonium SCHEMBL4146123 0.97 SLC22A1 (0.68) SLC22A1ALDH1A1TP53CYP3A4ALOX15
Tetrapentylammonium SCHEMBL6261128 0.97 SLC22A1 (0.63) SLC22A1ALDH1A1TP53CYP3A4ALOX15
Sulfuric Acid SCHEMBL2320651 0.97 SLC22A1 (0.68) SLC22A1ALDH1A1TP53CYP3A4ALOX15
Sulfuric Acid SCHEMBL6262541 0.95 SLC22A1 (0.59) SLC22A1ALDH1A1TP53CYP3A4ALOX15
Sulfuric Acid SCHEMBL6260170 0.95 SLC22A1 (0.59) SLC22A1ALDH1A1TP53CYP3A4ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 96 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250171409-A1 PROCESS OF PREPARATION OF INDOXACARB AND ITS INTERMEDIATES ADAMA MAKHTESHIM LTD. (IL) 2025-05-29 US claimed
EP-4460499-A1 PROCESS OF PREPARATION OF INDOXACARB AND ITS INTERMEDIATES ADAMA MAKHTESHIM LTD. (IL) 2024-11-13 EP claimed
WO-2023131943-A1 PROCESS OF PREPARATION OF INDOXACARB AND ITS INTERMEDIATES ADAMA MAKHTESHIM LTD. (IL) 2023-07-13 WO claimed
EP-3658523-B1 PROCESS FOR PREPARING (Z)-1,1,1,4,4,4-HEXAFLUORO-2-BUTENE CHEMOURS CO FC LLC (US) 2023-04-26 EP claimed
US-20210017106-A1 PROCESS FOR PREPARING (Z)-1,1,1,4,4,4-HEXAFLUORO-2-BUTENE THE CHEMOURS COMPANY FC, LLC (US) 2021-01-21 US claimed
EP-3658523-A1 PROCESS FOR PREPARING (Z)-1,1,1,4,4,4-HEXAFLUORO-2-BUTENE The Chemours Company FC, LLC (US) 2020-06-03 EP claimed
WO-2019023572-A1 PROCESS FOR PREPARING (Z)-1,1,1,4,4,4-HEXAFLUORO-2-BUTENE THE CHEMOURS COMPANY FC, LLC (US) 2019-01-31 WO claimed
US-20190031582-A1 Process for Preparing (Z)-1,1,1,4,4,4-Hexafluoro-2-Butene JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT 2019-01-31 US claimed
EP-2922809-A1 DEHYDROCHLORINATION OF CHLORINATED REACTANTS TO PRODUCE 1,1,1,4,4,4-HEXAFLUORO-2-BUTYNE E. I. du Pont de Nemours and Company (US) 2015-09-30 EP claimed
US-20150203423-A1 Dehydrochlorination of HCFC -336 Isomers to 1,1,1,4,4,4-Hexafluoro-2-Butyne E I DU PONT DE NEMOURS AND COMPANY (US) 2015-07-23 US claimed
US-7696366-B2 Production process of bifunctional epoxy monomer by selective oxidation of diolefin compound SHOWA DENKO K.K. (JP) 2010-04-13 US claimed
US-7541312-B2 Porous carbons from carbohydrates TDA RESEARCH, INC. (US) 2009-06-02 US claimed
EP-1725497-A4 POROUS CARBONS FROM CARBOHYDRATES TDA RESEARCH INC (US) 2008-11-05 EP claimed
EP-1725497-A2 POROUS CARBONS FROM CARBOHYDRATES TDA RESEARCH, INC. (US) 2006-11-29 EP claimed
US-20060216828-A1 Rapid-response reversible dry surface CO2 detector MERCURY ENTERPRISE, INC. 2006-09-28 US claimed
WO-2005089145-A2 POROUS CARBONS FROM CARBOHYDRATES TDA RESEARCH, INC. (US) 2005-09-29 WO claimed
US-20050207962-A1 Porous carbons from carbohydrates TDA RESEARCH, INC. (US) 2005-09-22 US claimed
EP-4747225-A2 A PROCESS TO PRODUCE 1252ZC FROM 1230XA OR 252DC AND COMPOSITIONS THEREOF The Chemours Company FC, LLC (US) 2026-05-27 EP disclosed
US-20020082348-A1 Process for producing an epoxidized polymer KURARAY CO. LTD, (JP) 2002-06-27 US disclosed
EP-1217011-A1 Process for producing an expoxidized polymer KURARAY CO., LTD. (JP) 2002-06-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250171409-A1 PROCESS OF PREPARATION OF INDOXACARB AND ITS INTERMEDIATES DDT, IDO2, INSR SLC22A1 3135/4885ALDH1A1 1545/4885TP53 4475/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.